This is the first phase 1 study to explore dual antigen-targeting CAR-T cells in DLBCL. The very preliminary phase 1 data suggests several agents will be pushing to larger trials. It is not clear how important antigen escape is following CD19-targeted CART cells but these trials might give us a clue.
Log In with AHPRA